Structure Networks, Inc.

Director

• Responsible for Structure Therapeutics’ small molecule Technical Operations projects in terms of the development of drug substances
• Support late-stage drug substance activities in contract development and manufacturing organizations (CDMOs)
• Focus on late stage and commercialization readiness
• Manage all interactions with CRO’s or CDMOs to ensure delivery of high-quality results and reports in time to meet regulatory requirements, including GxPs
• Accountable for the delivery of proper documents for regulatory filings
• Develop robust and scalable synthetic routes suitable for commercialization
• Direct CRO teams to perform experiments to define process parameters intended to develop suitable processes for chemical manufacturing and commercialization
• Monitor the progress of projects and provide technical solutions to CRO and CDMOs

Associate Director – Director of Drug Substance

Customer Retention Specialist

• Support the design and execution of patient recruitment
• Collaborate with study teams to identify the target population
• Develop and implement study plans for recruitment and retention
• Build and maintain relationships with sites, CROs, and vendors
• Conduct market research to understand patient needs
• Create Site and Participant facing documents/materials

Retention Specialist – Clinical

• Build relationships with Key Opinion Leaders (KOLs), academic institutions, and healthcare providers
• Present clinical and scientific data on metabolic therapies
• Lead high-level scientific discussions on disease state and treatment landscape
• Generate and execute the Field Medical Plan aligned with global medical strategy
• Lead the build-out and hiring of the Field Medical organization
• Identify insights from the field and translate them into actionable strategy
• Collaborate with internal stakeholders (Preclinical, Clinical Development, Operations, Commercial, Regulatory, Legal)
• Support Investigator-Initiated Trials (IITs) and real-world evidence studies
• Gather and synthesize medical insights from HCP interactions
• Inform clinical development plans and lifecycle management

Senior Director, Field Medical Lead – Obesity and Metabolic Programs

Medical Director

• Lead the development and execution of the Medical Strategy
• Gathering and synthesizing external insights across all metabolic programs
• Build and sustain relationships with key opinion leaders and investigators
• Support Investigator-Initiated Trials (IITs) and real-world evidence studies
• Partner with clinical development and commercial teams on trial design considerations

Associate Director – Director of Drug Substance

Retention Specialist – Clinical

Senior Director, Field Medical Lead – Obesity and Metabolic Programs

Senior Director, Medical Director – Obesity and Metabolic Programs